Rifaximin

Indication

Rifaximin as second line antibacterial treatment for the treatment of Small Intestinal Bacterial Overgrowth

Red

Brand:

Nice TA:

Commissioning responsibility:

CCG

PbR excluded:

BNF chapter:

Infection

Background

For the treatment of small intestinal bacterial overgrowth (SIBO) in patients who have failed to respond to either Co-amoxiclav, or Metronidazole plus cefalexin or trimethoprim / sulfamethoxazole.

Recommendation

LSCMMG Recommendation:

Red

Reason for decision:

Specialist medicine

Supporting documents:

Rifaximin New Medicine Assessment Approved

Decisions of Lancashire local decision making groups

BwD	BP	CSR	EL	FW	GP	MB	WL
Red	Red	Red	Red	Red	Red	Red	Red

What do the colours mean?

Last Updated: 14 - Jan - 2020

Breadcrumb

Rifaximin

Indication

Background

Recommendation

Decisions of Lancashire local decision making groups